SEARCH

SEARCH BY CITATION

References

  • Altena, K., Guder, A., Cramer, C., and Bierbaum, G. (2000) Biosynthesis of the lantibiotic mersacidin: organization of type B lantibiotic gene cluster. Appl Environ Microbiol 66: 25652571.
  • Baltz, R. (1998) Genetic manipulation of antibiotic-producing Streptomyces. Trends Microbiol 6: 7683.
  • Bentley, S.D., Chater, K.F., Cerdeño-Tárraga, A.-M., Challis, G.L., Thomson, N.R., James, K.D., et al. (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417: 141147.
  • Bierbaum, G., Szekat, C., Josten, M., Heidrich, C., Kempter, C., Jung, G., and Sahl, H.-G. (1996) Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol 62: 385392.
  • Bierman, M., Logan, R., O'Brien, K., Seno, E.T., Rao, N., and Schoner, B.E. (1992) Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene 116: 4349.
  • Brötz, H., Bierbaum, G., Leopold, K., Reynolds, P.E., and Sahl, H.-G. (1998) The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 42: 154160.
  • Chatterjee, C., Paul, M., Xie, L., and Van Der Donk, W.A. (2005) Biosynthesis and mode of action of lantibiotics. Chem Rev 105: 633683.
  • Cooper, L.E., McClerren, A.L., Chary, A., and Van Der Donk, W.A. (2008) Structure – activity relationship studies of the two – component lantibiotic haloduricin. Chem Biol 15: 10351045.
  • Cotter, P.D., Deegan, L.H., Lawton, E.M., Draper, L.A., O'Connor, P.M., Hill, C., and Ross, R.P. (2006) Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 62: 735747.
  • Fitzgerald, N.B., English, S., Lampel, J.S., and Vanden Boom, T.J. (1998) Sonication-dependent electroporation of the erythromycin-producing bacterium Saccharopolyspora erythraea. Appl Environ Microbiol 64: 15801583.
  • Gartemann, K.-H., Abt, B., Bekel, T., Burger, A., Engemann, J., Flügel, M., et al. (2008) The genome sequence of the tomato-pathogenic actinomycete Clavibacter michiganensis subsp. michiganensis NCPPB382 reveals a large island involved in pathogenicity. J Bacteriol 190: 21382149.
  • Gravesen, A., Kallipolitis, B., Holmstrøm, K., Høiby, P.E., Ramnath, M., and Knøchel, S. (2004) pbp2229-Mediated nisin resistance mechanism in Listeria monocytogenes confers cross-protection to class IIa bacteriocins and affects virulence gene expression. Appl Environ Microbiol 70: 16691679.
  • Guder, A., Schmitter, T., Wiedemann, I., Sahl, H.-G., and Bierbaum, G. (2002) Role of the single regulator MrsRI and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity. Appl Environ Microbiol 68: 106113.
  • Gust, B., Chandra, G., Jakimowicz, D., Yuqing, T., Bruton, C.J., and Chater, K.F. (2004) λ Red-mediated genetic manipulation of antibiotic-producing Streptomyces. Adv Appl Microbiol 54: 107128.
  • Héchard, Y., and Sahl, H.-G. (2002) Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 84: 545557.
  • Heidrich, C., Pag, U., Josten, M., Metzger, J., Jack, R.W., Bierbaum, G., et al. (1998) Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol 64: 31403146.
  • Heinzelmann, E., Berger, S., Puk, O., Reichenstein, B., Wohlleben, W., and Schwartz, D. (2003) A glutamate mutase is involved in the biosynthesis of the lipopeptide antibiotic friulimicin in Actinoplanes friuliensis. Antimicrob Agents Chemother 47: 447457.
  • Holo, H., Jeknic, Z., Daeschel, M., Stevanovic, S., and Nes, I.F. (2001) Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology 147: 643651.
  • Holtsmark, I., Mantzilas, D., Eijsink, V.G.H., and Brurberg, M.B. (2006) Purification, characterization, and gene sequence of Michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis. Appl Environ Microbiol 72: 58145821.
  • Horsburgh, M.J., Aish, J.L., White, I.J., Shaw, L., Lithgow, J.K., and Foster, S.J. (2002) δB Modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184: 54575467.
  • Ihnkunen, L.A.F., Chatterjee, C., and Van Der Donk, W.A. (2008) In vitro reconstitution and substrate specificity of a lantibiotic protease. Biochemistry 47: 73527363.
  • Kieser, T., Bibb, M.J., Buttner, M.J., Chater, K.F., and Hopwood, D.A. (2000) Practical Streptomyces Genetics. Norwich, UK: The John Innes Foundation.
  • McClerren, A.L., Cooper, L.E., Quan, C., Thomas, P.M., Kelleher, N.L., and Van Der Donk, W.A. (2006) Discovery and in vitro biosynthesis of haloduracin a two-component lantibiotic. Proc Natl Acad Sci U S A 103: 1724317248.
  • Nagao, J.-I., Aso, Y., Shioya, K., Nakayama, J., and Sonomoto, K. (2007) Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering. J Mol Microbiol Biotechnol 13: 235242.
  • Navaratna, M.A.D.B., Sahl, H.-G., and Tagg, J.R. (1998) Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol 64: 48034808.
  • NCCLS. (2003) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 6th edn. Approved standard guideline M7-A6. Wayne, PA: NCCLS. ISBN: 1-56238-486-4.
  • Ottenwälder, B., Kupke, T., Brecht, S., Gnau, V., Metzger, J., Jung, G., and Götz, F. (1995) Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl Environ Microbiol 61: 38943903.
  • Pag, U., Heindrich, C., Bierbum, G., and Sahl, H.-G. (1999) Molecular analysis of expression of the lantibiotic pep5 immunity phenotype. Appl Environ Microbiol 65: 591598.
  • Parenti, F., Coronelli, C., Tamoni, G., and Lancini, G. (1977) Gardimycin and process for producing same. US patent 4022884.
  • Patton, G.C., Paul, M., Cooper, L.E., Chatterjee, C., and Van Der Donk, W.A. (2008) The importance of the leader sequence for directing lanthionine formation in lacticin 481. Biochem 47: 73427351.
  • Prasch, T., Naumann, T., Market, R.L.M., Sattler, M., Schubert, W., Schaal, S., et al. (1997) Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics. Eur J Biochem 244: 501512.
  • Rodriguez, E., Hu, Z., Ou, S., Volchegursky, Y., Hutchinson, C.R., and McDaniel, R. (2003) Rapid engineering of polyketide overproduction by gene transfer to industrially optimized strains. J Ind Microbiol Biotechnol 30: 480488.
  • Ryan, M.P., Jack, R.W., Josten, M., Sahl, H.-G., Jung, G., Ross, R.P., and Hill, C. (1999) Extensive post-translational modification, including serine to d-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem 274: 3754437550.
  • Vértesy, L., Aretz, W., Bonnefoy, A., Ehlers, E., Kurz, M., Markus, A., et al. (1999) Ala(0) -actagardine, a new lantibiotic from cultures of Actinplanes liguriae ATCC 31048. J Antibiot 52: 730741.
  • Widdick, D.A., Dodd, H.M., Barraille, P., White, J., Stein, T.H., Chater, K.F., et al. (2003) Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005. Proc Natl Acad Sci U S A 100: 43164321.
  • Willey, J.M., and Van Der Donk, W.A. (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61: 477501.
  • Zimmerman, N., and Jung, G. (1997) The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR. Eur J Biochem 246: 809819.
  • Zimmerman, N., Metzger, J.W., and Jung, G. (1995) The tetracyclic lantibiotic actagardine 1H-NMR and 13C-NMR assignments and revised primary structure. Eur J Biochem 228: 786797.
    Direct Link: